Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma by Steve Jones and Martin Lane January 31, 2023February 2, 2023 Althea Althea has said it is “on the verge” of becoming cash flow positive as it […]
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
Strategic review continues at Elixinol as management mull sale or merger by Steve Jones May 4, 2022April 29, 2024
Elixinol Wellness boss steps down with sale or merger still on the cards by Martin Lane March 28, 2022April 29, 2024
All options on the table for Elixinol as losses narrow by 50% by Martin Lane February 28, 2022April 29, 2024
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022April 29, 2024
Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021April 29, 2024
